Dengue vaccines: what we know, what has been done, but what does the future hold?

作者：Abrao Emiliana Pereira; Alves Esposito Danillo Lucas; Lauretti Flavio; Lopes da Fonseca Benedito Antonio

来源：Revista de Saude Publica, 2015, 49(0): 60.

DOI：10.1590/S0034-8910.2015049006146

• Dengue Vaccines
• Dengue, prevention & control
• Scientific Research and Technological Development
• Communicable Disease Control

Dengue, a disease caused by any of the four serotypes of dengue viruses, is the most important arthropod-borne viral disease in the world in terms of both morbidity and mortality. The infection by these viruses induces a plethora of clinical manifestations ranging from asymptomatic infections to severe diseases with involvement of several organs. Severe forms of the disease are more frequent in secondary infections by distinct serotypes and, consequently, a dengue vaccine must be tetravalent. Although several approaches have been used on the vaccine development, no vaccine is available against these viruses, especially because of problems on the development of a tetravalent vaccine. Here, we describe briefly the vaccine candidates available and their ability to elicit a protective immune response. We also discuss the problems and possibilities of any of the vaccines in final development stage reaching the market for human use.

• 出版日期2015